On December 6, U.S. District Judge for the Southern District of Florida, Judge Robin L. Rosenberg granted summary judgment in favor of defendants Pfizer, Boehringer Ingelheim, GlaxoSmithKline (GSK) and Sanofi, in MDL 2924 – In Re: Zantac (Ranitidine) Products...
The Florida federal judge overseeing the Zantac multidistrict litigation has dismissed all claims, without leave to amend, against manufacturers of ranitidine, the generic or store brand version of the prescription medication Zantac, citing federal law preemption. On...
There have been a number of groups affected by the pending MDL involving Zantac, the popular heartburn medication. It is alleged that the defendants knew that Zantac was hazardous to consumers for years, but it only became publicly known in September, 2019 when the...
On Friday, May 8th, District Judge Robin Rosenberg, of the U.S. District Court for the Southern District of Florida, appointed 26 lawyers to a range of leadership positions to the Zantac MDL that was transferred to Florida last February. Initially, the Judge had...
On April 1, 2020, the FDA requested the recall of all ranitidine heartburn medication products (commonly known by the brand name Zantac) because of the risks posed by NDMA contamination in some samples tested. Last week, Judge Robin L. Rosenberg, who is presiding over...
On April 1st, the FDA announced a global halt of the heartburn medication ranitidine, sold under the brand name of Zantac. This follows an initial warning back in September 2019, when low levels of a toxic compound and probable human carcinogen, NDMA...
On February 6th, the JPML released an order that will send over 140 lawsuits involving injuries caused by the heartburn medication Zantac to the Southern District of Florida. The judge assigned to preside over the consolidated cases, The Honorable Robin L. Rosenberg,...
888-681-1129